EMMA REEVE
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
JAMES E. AUDIA, GAREN BOHLIN, SCOTT BRAUNSTEIN, MICHAEL R. COOPER, KEITH DIONNE, ANTHONY EVNIN, DAVID GOEDDEL, MARK A. GOLDSMITH, EDWARD E. HARLOW, JR., STEVEN HOERTER, MATTHIAS JAFFE, MARK LEVIN, TOM MANIATIS, STEVEN PAUL, JIGAR RAYTHATHA, KERRY K. REINERTSEN, ADRIAN SENDEROWICZ, PETER SVENNILSON, ROBERT TEPPER, ELIZABETH G. TREHU, PATRICK TROJER, KAREN VALENTINE
DIRECTOR
RICHARD ALDRICH, NEIL ALMSTEAD, NEIL ALMSTEAD, PH.D, WILLIAM BAIRD, III, AXEL BOLTE, MARK E. BOULDING, SOREN CARLSEN, CARL GOLDFISCHER, EMILY HILL, CLAUDIA HIRAWAT, ALLAN S. JACOBSON, ALLAN JACOBSON, PH.D., MATTHEW KLEIN, MATTHEW B. KLEIN, MATTHEW B. KLEIN, M.D., ADAM KOPPEL, MICHAEL KRANDA, GEOFFREY MCDONOUGH, LANGDON L. MILLER, LANGON L. MILLER, STEPANIE S. OKEY, STEPHANIE S. OKEY, DEEPA PAKIANATHAN, ERIC PAUWELS, STUART W. PELTZ, MICHAEL SCHMERTZLER, MARY SMITH, DAVID P. SOUTHWELL, MARCIO SOUZA, GLENN D. STEELE JR., M.D., PH.D., GLENN D. STEELE, JR., PETER SVENNILSON, DAWN SVORONOS, CHRISTINE UTTER, ALETHIA YOUNG, JEROME B. ZELDIS, JEROME B. ZELDIS, M.D., PH.D.
DIRECTOR
DIRECTOR
BEHZAD AGHAZADEH, BRYAN BALL, CALEY CASTELEIN, ANUPAM DALAL, BRENDAN DELANEY, NEIL DESAI, DAVID DORNAN, PRAVIN DUGEL, JOSEPH GARDNER, SCOTT GIACOBELLO, KARIN HEHENBERGER, KARIN HENEBERGER, MOHAMMAD HIRMAND, LORETTA ITRI, CHAU KHUONG, DAVE LENNON, RICHARD MAROUN, JAMES MURPHY, STEPHEN PAKOLA, KEVIN G. PETERS, STEVEN PRELACK, MUNEER SATTER, LANCE THIBAULT, PAUL M. WEISS, BAITENG ZHAO
DIRECTOR
DIRECTOR
KATHRYN ABSHIRE, MERT AKTAR, KENJI CUNNION, FRANK GADAMS, DEBORAH GERAGHTY, LAURIE GLIMCHER, JOHN HARDING, EDWARD HEIDT, JR., NEEL KRISHNA, DAVID MAREK, PAOLO MARTINI, THOMAS KERRY MCCARTER, ANDREW MILLER, AZMI NABULSI, JERRY NADLER, CHRISTINE NEIKIRK, JOHN RICKMAN, CHRISTI SHAW, BARRY STRASNICK, ULRICH THIENEL, LEWIS WILLIAMS, JONATHAN ZALEVSKY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-03-04
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-04-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-08-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-08-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-06-01
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-04-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-10-01

